From RNA biologics and therapeutic modalities to enabling technologies and the clinical, regulatory and commercial work that brings them to patients — 33 topics across four sessions.
Discovery, design and expression of RNA-based biologics, vaccines and protein-replacement platforms.
The modalities that silence, edit, modulate and correct gene expression to treat disease.
The design, delivery, manufacturing and analytical tools that turn RNA candidates into viable medicines.
From preclinical safety and PK/PD to regulatory strategy and market access.
Secure your place among the global RNA therapeutics community in San Francisco, 28 – 30 June 2027.
Register Now